BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15050901)

  • 1. In vivo bone metastases, osteoclastogenic ability, and phenotypic characterization of human breast cancer cells.
    Rucci N; Ricevuto E; Ficorella C; Longo M; Perez M; Di Giacinto C; Funari A; Teti A; Migliaccio S
    Bone; 2004 Apr; 34(4):697-709. PubMed ID: 15050901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PYK2 autophosphorylation, but not kinase activity, is necessary for adhesion-induced association with c-Src, osteoclast spreading, and bone resorption.
    Lakkakorpi PT; Bett AJ; Lipfert L; Rodan GA; Duong LT
    J Biol Chem; 2003 Mar; 278(13):11502-12. PubMed ID: 12514172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MMP-13 stimulates osteoclast differentiation and activation in tumour breast bone metastases.
    Pivetta E; Scapolan M; Pecolo M; Wassermann B; Abu-Rumeileh I; Balestreri L; Borsatti E; Tripodo C; Colombatti A; Spessotto P
    Breast Cancer Res; 2011 Oct; 13(5):R105. PubMed ID: 22032644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer cells induce osteoclast formation by stimulating host IL-11 production and downregulating granulocyte/macrophage colony-stimulating factor.
    Morgan H; Tumber A; Hill PA
    Int J Cancer; 2004 May; 109(5):653-60. PubMed ID: 14999770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. v-Src rescues actin-based cytoskeletal architecture and cell motility and induces enhanced anchorage independence during oncogenic transformation of focal adhesion kinase-null fibroblasts.
    Moissoglu K; Gelman IH
    J Biol Chem; 2003 Nov; 278(48):47946-59. PubMed ID: 14500722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of osteoclast function by adenovirus expressing antisense protein-tyrosine kinase 2.
    Duong LT; Nakamura I; Lakkakorpi PT; Lipfert L; Bett AJ; Rodan GA
    J Biol Chem; 2001 Mar; 276(10):7484-92. PubMed ID: 11102447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-SRC tyrosine kinase activity is associated with tumor colonization in bone and lung in an animal model of human breast cancer metastasis.
    Myoui A; Nishimura R; Williams PJ; Hiraga T; Tamura D; Michigami T; Mundy GR; Yoneda T
    Cancer Res; 2003 Aug; 63(16):5028-33. PubMed ID: 12941830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficiency in the phosphatase PHLPP1 suppresses osteoclast-mediated bone resorption and enhances bone formation in mice.
    Mattson AM; Begun DL; Molstad DHH; Meyer MA; Oursler MJ; Westendorf JJ; Bradley EW
    J Biol Chem; 2019 Aug; 294(31):11772-11784. PubMed ID: 31189651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The MET/Vascular Endothelial Growth Factor Receptor (VEGFR)-targeted Tyrosine Kinase Inhibitor Also Attenuates FMS-dependent Osteoclast Differentiation and Bone Destruction Induced by Prostate Cancer.
    Watanabe K; Hirata M; Tominari T; Matsumoto C; Fujita H; Yonekura K; Murphy G; Nagase H; Miyaura C; Inada M
    J Biol Chem; 2016 Sep; 291(40):20891-20899. PubMed ID: 27539855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PYK2 in osteoclasts is an adhesion kinase, localized in the sealing zone, activated by ligation of alpha(v)beta3 integrin, and phosphorylated by src kinase.
    Duong LT; Lakkakorpi PT; Nakamura I; Machwate M; Nagy RM; Rodan GA
    J Clin Invest; 1998 Sep; 102(5):881-92. PubMed ID: 9727056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Src kinase activity is essential for osteoclast function.
    Miyazaki T; Sanjay A; Neff L; Tanaka S; Horne WC; Baron R
    J Biol Chem; 2004 Apr; 279(17):17660-6. PubMed ID: 14739300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-34 is expressed by giant cell tumours of bone and plays a key role in RANKL-induced osteoclastogenesis.
    Baud'huin M; Renault R; Charrier C; Riet A; Moreau A; Brion R; Gouin F; Duplomb L; Heymann D
    J Pathol; 2010 May; 221(1):77-86. PubMed ID: 20191615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway.
    Bendre MS; Margulies AG; Walser B; Akel NS; Bhattacharrya S; Skinner RA; Swain F; Ramani V; Mohammad KS; Wessner LL; Martinez A; Guise TA; Chirgwin JM; Gaddy D; Suva LJ
    Cancer Res; 2005 Dec; 65(23):11001-9. PubMed ID: 16322249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective tyrosine kinase inhibition of insulin-like growth factor-1 receptor inhibits human and mouse breast cancer-induced bone cell activity, bone remodeling, and osteolysis.
    Logan JG; Sophocleous A; Marino S; Muir M; Brunton VG; Idris AI
    J Bone Miner Res; 2013 May; 28(5):1229-42. PubMed ID: 23239200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of breast cancer cell line-derived paracrine factors that stimulate osteoclast activity.
    Pederson L; Winding B; Foged NT; Spelsberg TC; Oursler MJ
    Cancer Res; 1999 Nov; 59(22):5849-55. PubMed ID: 10582709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease.
    Bendre MS; Montague DC; Peery T; Akel NS; Gaddy D; Suva LJ
    Bone; 2003 Jul; 33(1):28-37. PubMed ID: 12919697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
    Valverde P; Tu Q; Chen J
    J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RAFTK/Pyk2 tyrosine kinase mediates the association of p190 RhoGAP with RasGAP and is involved in breast cancer cell invasion.
    Zrihan-Licht S; Fu Y; Settleman J; Schinkmann K; Shaw L; Keydar I; Avraham S; Avraham H
    Oncogene; 2000 Mar; 19(10):1318-28. PubMed ID: 10713673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Butyrate regulates the expression of c-Src and focal adhesion kinase and inhibits cell invasion of human colon cancer cells.
    Lee JC; Maa MC; Yu HS; Wang JH; Yen CK; Wang ST; Chen YJ; Liu Y; Jin YT; Leu TH
    Mol Carcinog; 2005 Aug; 43(4):207-14. PubMed ID: 16001424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of c-Src in cellular events associated with colony-stimulating factor-1-induced spreading in osteoclasts.
    Insogna K; Tanaka S; Neff L; Horne W; Levy J; Baron R
    Mol Reprod Dev; 1997 Jan; 46(1):104-8. PubMed ID: 8981371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.